Mutation and expression of the p53 gene during chemical hepatocarcinogenesis in F344 rats

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1628, Issue 1, 2003, Pages 40-49

  Fu, Yan ^a,b   Deng, Weiguo ^a   Kawarada, Yoshihiko ^a   Kawagoe, Masami ^a   Ma, Ying Zhe ^a   Li, Xinghua ^a   Guo, Naxin ^a   Kameda, Takashi ^a   Terada, Kunihiko ^a   Sugiyama, Toshihiro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JILIN UNIVERSITY   (China)

Author keywords

DAB; Hepatocarcinogenesis; Laser capture microdissection; p53; RT PCR

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0038692025     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(03)00113-1     Document Type: Article

References (49)

1. Malkin D., Li F.-P., Strong L.C., Fraumeni J.F. Jr., Nelson C.E., Kim D.H., Gryka M.A., Bischoff F.Z., Tainsky M.A., Friend S.H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmas. Science. 250:1990;1233-1238.
2. Boland C.R., Sato J., Appelman H.D., Bresalier R.S., Feinberg A.P. Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nat. Med. 1:1995;902-909.
3. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
4. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
5. Teeguarden J.G., Newton M.A., Dragan Y.P., Pitot H.C. Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20. Mol. Carcinog. 28:2000;51-61.
6. De Miglio M.R., Muroni M.R., Simile M.M., Virdis P., Asara G., Frau M., Calvisi D.F., Seddaiu M.A., Pascale R.M., Feo F. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain. Hepatology. 33:2001;1110-1117.
7. Kishimoto Y., Shiota G., Kamisaki Y., Wada K., Nakamoto K., Yamawaki M., Kotani M., Itoh T., Kawasaki H. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma. Oncology. 54:1997;304-310.
8. Ashida K., Kishimoto Y., Nakamoto K., Wada K., Shiota G., Hirooka Y., Kamisaki Y., Itoh T., Kawasaki H. Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 123:1997;489-495.
9. Oda T., Tsuda H., Scarpa A., Sakamoto M., Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:1992;6358-6364.
10. Harris C.C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 262:1993;1980-1981.
11. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
12. Sato K., Kitahara A., Satoh K., Ishikawa T., Tatematsu M., Ito N. The placental form of glutathione S-transferase as a new marker of protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann. 75:1984;199-202.
13. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C. J. Natl. Cancer Inst. 64:1980;177-206.
14. Sugioka Y., Fujii-Kuriyama Y., Kitagawa T., Muramatsu M. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis. Cancer Res. 45:1985;365-378.
15. Bonner R.F., Emmert-Buck M., Cole K., Pohida T., Chuaqui R., Goldstein S., Liotta L.A. Laser capture microdissection: molecular analysis of tissue. Science. 278:1997;1481-1483.
16. Tam A.S., Foley J.F., Devereux T.R., Maronpot R.R., Massey T.E. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Cancer Res. 59:1999;3634-3640.
17. Wittwer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., Balis U.J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. BioTechniques. 22:1997;176-181.
18. Lehman T.A., Haffty B.G., Carbone C.J., Bishop L.R., Gumbs A.A., Krishnan S., Shields P.G., Modali R., Turner B.C. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res. 60:2000;1062-1069.
19. Fakuda I., Ogawa K. Alternatively-spliced p53 mRNA in the FAA-HTC1 rat hepatoma cell line without the splice site mutations. Cell Struct. Funct. 17:1992;427-432.
20. Ohgaki H., Hard G.C., Hirota N., Maekawa A., Takahashi M., Kleihues P. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Cancer Res. 52:1992;2995-2998.
21. Weghorst C.M., Buzard G.S., Calvert R.J., Hulla J.E., Rice J.M. Cloning and sequence of a processed p53 pseudogene from rat: a potential source of false 'mutations' in PCR fragments of tumor DNA. Gene. 166:1995;317-322.
22. Lin Y., Chan S.-H. Cloning and characterization of two processed p53 pseudogenes from the rat genome. Gene. 156:1995;183-189.
23. Hulla J.E., Schneider R.P. Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res. 21:1993;713-717.
24. Masui T., Nakanishi H., Inada K., Imai T., Mizoguchi Y., Yada H., Futakuchi M., Shirai T., Tatematsu M. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes. Cancer Lett. 112:1997;33-45.
25. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350:1991;429-431.
26. Volkmann M., Hofmann W.J., Muller M., Rath U., Otto G., Zentgraf H., Galle P.R. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene. 9:1994;195-204.
27. Vancutsem P.M., Lazarus P., Williams G.M. Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by Tomoxifen. Cancer Res. 54:1994;3864-3867.
28. Mehta R. The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Lett. 93:1995;85-102.
29. Pascale R.M., Simile M.M., Feo F. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy. Anticancer Res. 13(5A):1993;1341-1356.
30. Haas M.J., Pitot H.C. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats. Mol. Carcinog. 21:1998;128-134.
31. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
32. Denissenko M.F., Koudriakova T.B., Smith L., O'Connor T.R., Riggs A.D., Pfeifer G.P. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats. Oncogene. 17:1998;3007-3014.
33. Hulla J.E., Chen Z.Y., Eaton D.L. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res. 53:1993;9-11.
34. Hsu I.-C., Metcalf R.A., Sun T., Welsh J.A., Wang N.-J., Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 350:1991;427-428.
35. Makino H., Ishizaka Y., Tsujimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutations in primary zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. U. S. A. 89:1992;4850-4854.
36. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 265:1994;346-355.
37. Liu Y.-P., Lin Y., Ng M.L. Immunochemical and genetic analysis of the p53 gene in liver preneoplastic nodules from aflatoxin-induced rats in one year. Ann. Acad. Med. Singap. 25:1996;31-36.
38. El-Mahdani N., Vaillant J.C., Guiguet M., Prevot S., Bertrand V., Bernard C., Parc R., Bereziat G., Hermelin B. Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation. Br. J. Cancer. 75:1997;528-536.
39. Okamoto M., Hattori K., Fujimoto K., Tanaka Y., Gloosby C.L., Oyasu R. Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells. Carcinogenesis. 19:1998;73-79.
40. Fu L.-N., Minden M.D., Benchimol S. Translational regulation of human p53 gene expression. EMBO J. 15:1996;4392-4401.
41. Murakami Y., Nobukuni T., Tamura K., Maruyama T., Sekiya T., Arai Y., Gomyou H., Tanigami A., Ohki M., Cabin D., Frischmeyer P., Hunt P., Reeves R.H. Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8153-8158.
42. Oren M., Maltzman W., Levine A.J. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:1981;101-110.
43. Sturzbecher H.W., Chumakov P., Welch W.J., Jenkins J.R. Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. Oncogene. 1:1987;201-211.
44. Milner J., Medcalf E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell. 65:1991;765-774.
45. Michalovitz D., Halevy O., Oren M. p53 mutations: gains or losses. J. Cell Biochem. 45:1991;22-29.
46. Hsu H.-C., Tseng H.-J., Lai P.-L., Lee P.-H., Peng S.-Y. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res. 53:1993;4691-4694.
47. Ng I.O.L., Srivastava G., Chung L.-P., Tsang S.W.Y., Ng M.M.T. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer. 74:1994;30-37.
48. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:1995;4442-4449.
49. Ono K., Tanaka T., Tsunoda T., Kitahara O., Kihara C., Okamoto A., Ochiai K., Takagi T., Nakamura Y. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60:2000;5005-5007.